Clinical Trial Update: Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring monocyte biomarkers in moderate to severe plaque psoriasis patients treated with apremilast; results completed with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2023-01-20